Daily Management Review

AstraZeneca & Ironwood In An Agreement On Zurampic Right


04/28/2016


The two pharmacists have arrived at an agreement whereby, they will support each other in developing gout treatment.



AstraZeneca has entered in a “licensing agreement” with the “Ironwood Pharmaceuticals” on the issue of “exclusive US rights to Zurampic”. The latter is used for treating “hyperuricemia” which results in “uncontrolled gout” problem.
 
The exclusive U.S. rights on Zurampic will be acquires by Ironwood for using the same in a “fixed-dose combination” which will involve “lesinurad and allopurinol”.
 
Moreover, AstraZeneca informed that it has plans of submitting the combination of the fixed dose to regulatory authorities for reviewing in the latter half of the year 2016, while Ironwood will make a payment to AstraZeneca for sales and other “milestone” related issues. The amount that will be paid by Ironwood to AstraZeneca is “$265m” in addition to “single-digit royalties on product sales”.
 
On the other hand, AstraZeneca will be manufacturing Zurampic and supply the same to Ironwood besides supporting some of Ironwood’s services. Furthermore, AstraZeneca will also be undertaking the “FDA post-approval commitment” on behalf of Ironwood.
 
 
References:
http://www.digitallook.com/







Science & Technology

Five loudest data leaks

Airbus announces Moon exploration competition

Former Head Of Google China Thinks Funding In AI Should Be Doubled By US

Germany Introduces The First Ever Train To Run On 100% Hydrogen

Germany Plans On Cyber Security Research To End Reliance On U.S. Tech

Fuchsia will kill Android by 2023: Top 5 facts about the new OS

New Study Finds Goats Interact More With Happy People

More than 32 thousand "smart" houses under threat of hacker attack

Internet addiction and children: Global plague

Apple takes up to develop Apple Watch for health monitoring

World Politics

World & Politics

Cyprus Cobalt Air stopped flights

Transparency International: Europe should stop selling citizenships

Turkey: We are not going to discuss borrowing from IMF anymore

Trump in your mobile phone: US is going to test Presidential Alert system

European automakers warn of consequences of tight emission controls

IATA: EU-UK flights can be cancelled due to Brexit disagreements

Ex-Brexit Minister Said A ‘Reset’ Is Needed For Brexit Talks

10 countries with the best healthcare systems